January 8, 2018 / 9:33 AM / 5 months ago

BRIEF-India's Orchid Pharma Gets EIR For Tamil Nadu Facility

Jan 8 (Reuters) - Orchid Pharma Ltd:

* GETS EIR FROM U.S. FDA-POST MARKETING ADVERSE DRUG EXPERIENCE REPORTING INSPECTION

* EIR RECEIVED FOR CO'S TAMIL NADU FACILITY Source text - bit.ly/2CO7kdA Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below